Abstract
Seventeen male patients with ischaemic heart disease (IHD) and effort angina performed OBLA exercise stress tests (set to 2.0 mmol × 1−1). They had muscle biopsies from the vastus lateralis muscle the day before coronary by-pass grafting, and from the internal and external intercostal, diaphragm and gastrocnemius muscles during surgery. They had a low WOBLA (83 ± 6 W, mean ± 1 S.E.M), WOBLA corresponded to 79 ± 4% (% WOBLA) of WSL (symptom limited or ‘maximal’ capacity = 111 ± 11 W). Peak blood lactate concentration averaged 2.9 mmol × 1−1. Muscle fibre composition disclosed a depressed percent slow twitch (ST or ‘red’) muscle fibres in the vastus lateralis and intercostal muscles (%ST). The diaphragm and gastrocnemius muscles had normal %ST. Intercostal muscles had elevated values for the fast twitch muscle fibre (FT) subgroup FTa indicative of endurance adaptation. The vastus lateralis, gastrocnemius and diaphragm muscles had normal muscle ubiquinone (UQ) contents, whereas the intercostals were depleted. Plasma contents of the antioxidants UQ and α-tocopherol were low as compared to healthy man.
Similar content being viewed by others
References
Just H, Drexler H, Zelis R: A symposium: regional blood flow in congestive heart failure. Am J Cardiol (suppl E) 62: 1–114, 1988
LeJemtel TH, Scortichini D, Katz S: Direct and indirect assessment of skeletal muscle blood flow in chronic congestive heart failure. Am J Cardiol (Suppl E) 62: 36–39, 1988
Wiener DH, Fink LI, Maris J, Jones RA, Chance B, Wilson JR: Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow. Circulation 73: 1127–1136, 1986
Massie B, Canway M, Yonge R, et al.: Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. Circulation 76: 1009–1019, 1987
Poole-Wilson PA, Buller NP, Lipkin DP: Regional blood flow, muscle strength and skeletal muscle histology in severe congestive heart failure. Am J Cardiol (Suppl E) 62: 49–52, 1988
Rajagopalan B, Conway MA, Massie B, Radda GK: Alterations of skeletal muscle metabolism in humans studied by phosphorus 31 magnetic resonance spectroscopy in congestive heart failure. Am J Cardiol (Suppl E) 62: 53–57, 1988
Andersen P: Capillary density in skeletal muscle of man. Acta Physiol Scand 95: 203–205, 1975
Braunwald E, Kloner R: Myocardial reperfusion: A double-edged sword? J Clin Invest 76: 1713–1719, 1985
Carlens P, Hindemarsh T, Holmgren A: Left ventricular pump function in effort angina. Europ J Cardiol 10: 475–191, 1979
Karlsson J: Onset of blood lactate accumulation, exercise capacity, skeletal muscle fibers and metabolism before and after coronary bypass grafting. Am J Cardiol (suppl E) 62: 108–114, 1988
Karlsson J: Exercise capacity and muscle fibre types in effort angina. Eur Heart J (suppl G) 8: 51–57, 1987
Karlsson J: Localized muscular fatigue: role of muscle metabolism and substrate depletion. In: R.S. Hutton, D.I. Miller (ed.). Exercise and Sports Sciences Review. Philadelphia: Franklin Institute Press, 1979, pp 1–42
Karlsson J, Diamant B, Folkers K, et al.: Ischemic heart disease, skeletal muscle fibers and exercise capacity. Eur Heart J 13: 758–762, 1992
Karlsson J, Lin L, Jansson E, Gunnes S, Sylvén C, Aström H: Muscle ubiquinone in male effort angina patients. Mol Cell Biochem 156: 173–178, 1996
Karlsson J, Lin L, Sylvén C, Jansson E: Muscle ubiquinone in healthy physically active males. Mol Cell Biochem 156: 169–172, 1996
Karlsson J, Jacobs I, Sjödin B, et al.: Semi-automatic blood lactate assay: Experiences from an exercise laboratory. Int J Sports Med 4: 52–55, 1982
Bergström J, Hermansen L, Hultman E, Saltin B: Diet, muscle glycogen and physical performance. Acta Physiol Scand 71: 140–150, 1967
Karlsson J: Lactate and phosphagen concentrations in working muscle of man. Acta Physiol Scand Suppl 358: 1–72, 1971
Edlund P-O: Determination of coenzyme Q10, α-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detection. Journ Chromat 425: 87–97, 1988
Johansen K, Theorell H, Karlsson J, Diamant B, Folkers K: Coenzyme Q10, alpha-tocopherol and free cholesterol in HDL and LDL fractions. Annals Med 23: 649–656, 1991
Karlsson J, Diamant B, Folkers K: Exercise-limiting factors in respiratory distress. Respiration 59: 18–23, 1992
Mizuno M, Secher NH: Histochemical characteristics of human expiratory and inspiratory muscles. J Appl Physiol 67: 592–598, 1989
Karlsson J: The antioxidant strategy and exercise. Champaign, IL: Human Kinetics Publishers, Inc, 1996: In print
Karlsson J: Heart and skeletal muscle ubiquinone or CoQ10 as a protective agent against radical formation in man. In: G. Benzi (ed.). Advances in Myochemistry. London: John Libbey, 1987, pp 305–318
Emster L, Lee I-Y, Norling B: Studies with ubiquinone-depleted submitochondrial particles. Essentiality of ubiquinone for the interaction of suceinate dehydrogenase, NAD dehydrogenase and cytochrome b. Eur J Biochem 9: 299–310, 1969
Beyer RE, Emster L: The antioxidant role of coenzyme Q. In: G. Lenaz, O. Bamabei, A. Rabbi, M. Battino (ed.). Highlights in Ubiquinone Research. London: Taylor and Francis, 1990, pp 191–213
Emster L, Beyer RE: Antioxidant functions of coenzyme Q: some biochemical and pathophysiological implications. In: K. Folkers, G.P. Littarru, T. Yamagami (eds). Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam: Elsevier, 1991, pp 45–58
Packer L, Kagan V, Serbinova E: Participation of ubiquinones in membrane antioxidation: direct radical scavenging or tocopherol recycling. In: K. Folkers, G.P. Littarru, T. Yamagami (eds). Biomedical and Clinical Aspects of Coenzyme Q. Biomedical and clinical aspects of coenzyme Q. Elsevier, 1991, pp 115–123
Gey FK: Vitamin E and other essential antioxidants regarding coronary heart disease: risk assessment studies. In: L. Packer, J. Fuchs (ed.). Vitamin E in Health and Disease. New York: Marcel Dekker Inc., 1993, pp 589–633
Karlsson J, Diamant B, Theorell H, Johansen K, Folkers K: Plasma alpha-tocopherol and ubiquinone and their relations to muscle function in healthy human and in cardiac diseases. In: L. Packer, J. Fuchs (eds). Vitamin E: Biochemistry and Clinical Applications. New York: Marcel Dekker, Inc, 1993, pp 473–493
Mortensen SA, Heidt P, Sehested J: Clinical perspectives in the treatment of cardiovascular diseases with coenzyme Q10. In: G. Lenaz, O. Bamabei, A. Rabbi, M. Battino (eds). Highlights in Ubiquinone Research: London, 1990, pp 226–231
Wilson MF, Frishman WH, Giles T, Sethi G, Greenberg SM, Brackett DJ: Coenzyme Q10 therapy and exercise duration in stable angina. In: K. Folkers, G.P. Littarru, T. Yamagami (eds). Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam: Elsevier, 1991, pp 339–348
Hofman-Bang C, Rehnqvist N, Swedberg K: Coenzyme Q10 as and adjunctive treatment of congestice heart failure (for the Q10 Study Group 1992). J Am Coll Cardiol 19: 216A, 1992
Stocker R, Bowry VW, Frei B: Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci USA 88: 1646–1650, 1991
Esterbauer H, Puhl H, Waeg G, Krebs A, Dieber-Rothender M: The role of vitamin E in lipoprotein oxidation. In: L. Packer, J. Fuchs (ed.). Vitamin E in Health and Disease. New York: Marcel Dekker Inc., 1993, pp 649–671
Mortensen S-A: Perspectives on therapy of cardiovascular artery diseases with coenzyme Q10 (Ubiquinone). Clin Inv 71: S 116-S 123, 1993
Mizuno M: Human respiratory muscles: fibre morphology and capillary supply. Eur Respir J 4: 587–601, 1991
Author information
Authors and Affiliations
Additional information
The study was carried out by the Department of Thoracic Surgery, Karolinska Hospital, Stockholm, Sweden.
Rights and permissions
About this article
Cite this article
Karlsson, J., Gunnes, S. & Semb, B. Muscle fibers, ubiquinone and exercise capacity in effort angina. Mol Cell Biochem 156, 179–184 (1996). https://doi.org/10.1007/BF00426342
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00426342